Eli Lilly Weight Loss Pill

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

Viking said that an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body weight in four weeks.

Yahoo · 4d

Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster weight loss drug Zepbound was not dragging down sales. Pfizer sales rose 31% to $17.

MarketWatch on MSN · 2d

Viking Therapeutics stock jumps after ‘great’ trial of weight-loss drug

Viking Therapeutics stock rose in early trade on Monday as the company showed its oral weight-loss drug in clinical trials was successful.

Kiplinger on MSN · 1d

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

Yahoo · 6d

Knockoff weight loss drugs are having a moment. Eli Lilly isn't worried

CEO David Ricks said the sale of cheaper, off-brand versions of the company’s blockbuster weight loss drug isn’t having a “financial impact” on the pharma giant.

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not ...

Futurism3d

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" in its most recent quarterly sales announcement: in spite of bottomless ...

STAT26d

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

There’s a war brewing over blockbuster weight loss medications — and patients ... Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name ...

Wall Street Lunch: Viking Weight-Loss Pill Data Is Striking

VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound, ...

NBC New York22d

Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

The Eli Lilly deal includes a "real-world" study into how its weight-loss drugs impact "participants' employment status and sick days," among other factors. LONDON — U.S. pharmaceutical giant ...